ACHROMATOPSIA

Clinical trials for ACHROMATOPSIA explained in plain language.

Never miss a new study

Get alerted when new ACHROMATOPSIA trials appear

Sign up with your email to follow new studies for ACHROMATOPSIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could an existing drug restore color vision in rare blindness?

Symptom relief Terminated

This early-phase study tests whether glycerol phenylbutyrate (PBA), a drug already approved for other conditions, can improve vision in people with a rare inherited form of color blindness (achromatopsia) caused by ATF6 gene mutations. Two adults with the condition will take PBA …

Matched conditions: ACHROMATOPSIA

Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Symptom relief

Last updated May 14, 2026 12:03 UTC

ACHROMATOPSIA

Get alerted when new ACHROMATOPSIA trials appear

Could an existing drug restore color vision in rare blindness?